Transasia Bio-Medicals Limited

Transasia Bio-Medicals Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U33110MH1985PLC036198 Incorporated 10 May 1985 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company healthcare
Revenue · FY 2025
₹1,097.22 Cr
▼ 9% YoY
Net profit · FY 2025
₹202.19 Cr
Net margin 18.4%
EBITDA · FY 2025
₹290.8 Cr
EBITDA margin 26.5%
Authorised capital
₹4.4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹108 Cr
Satisfied ₹999.7 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
1,323
Provident fund records

About Transasia Bio-Medicals Limited

Data last updated:

Transasia Bio-Medicals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 10 May 1985 and has been in existence for over 41 years.

Its director Suresh H Vazirani and family are #416 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH1985PLC036198. Its GSTIN is 27AAACT2038C1ZT (Maharashtra). The company holds 18 GST registrations, of which 12 are active.

The company has an authorised share capital of ₹4.4 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Sunil Hassanand Vazirani (Whole-Time Director) and Suresh Hassanand Vazirani.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Transasia House 8 Chandivali Studio Road, Mumbai, Maharashtra, India – 400072.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,097.22 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹202.19 Cr (net margin 18.4%) and EBITDA of ₹290.8 Cr (EBITDA margin 26.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.

The company has about 1,323 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries and 1 joint venture.

The company is associated with 2 brands: Care Data Infomatics and Transasia Bio-Medicals. As per MCA filings, the company has open charges of ₹108 Cr and satisfied charges of ₹999.7 Cr on record. Court records list 15,950 cases involving the company, including 15,815 filed by the company and 136 filed against it; 4,840 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2008. The company has 12 MSME Form 1 returns on record between 2018 and 2024, listing 194 overdue payments to 60 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website transasia.co.in.

Company details

CIN U33110MH1985PLC036198
Registration Number 036198
Incorporation Date 10 May 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Transasia Bio-Medicals has one previous CIN (Corporate Identification Number): L33110MH1985PLC036198. The current CIN is U33110MH1985PLC036198, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33110MH1985PLC036198Current
L33110MH1985PLC036198Previous

Recognitions & Rankings of Transasia Bio-Medicals

India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#314
Valuation
₹17,880 Cr
2023 #301 2022 #332 2021 #354

Contact details

Transasia Bio-Medicals Limited's registered office is in Mumbai, Maharashtra. Its website is transasia.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Transasia House 8 Chandivali Studio Road, Mumbai, Maharashtra, India – 400072
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Transasia Bio-Medicals Limited, buy the company report.

Comprehensive company report
Transasia Bio-Medicals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Transasia Bio-Medicals operates two associated brands: Care Data Infomatics and Transasia Bio-Medicals. Each brand links to its own profile.

BrandDescriptionWebsite
Provides cloud-based LIMS software for lab automation, data management, and efficiency improvements.caredatainfo.com
Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutionstransasia.co.in

Business activity

The main business activities of Transasia Bio-Medicals are manufacturing, trade and support service to organizations. 4 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities
GTradeG2Retail Trading
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Transasia Bio-Medicals Limited, buy the company report.

Financials of Transasia Bio-Medicals Limited

FY 2025 filings available

Transasia Bio-Medicals Limited reported revenue of ₹1,097.22 Cr (down 9% YoY) for FY 2025.

Revenue · FY 2025
₹1,097.22 Cr ▼ 9%
Net profit · FY 2025
₹202.19 Cr margin 18.4%
EBITDA · FY 2025
₹290.8 Cr margin 26.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 2%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 4%
5 years · compounded
▲ 3%

Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1,097.22 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹290.8 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹202.19 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin26.5%
Net Profit Margin18.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Transasia Bio-Medicals Limited, buy the company report.

Board of directors of Transasia Bio-Medicals Limited

Transasia Bio-Medicals has 9 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunil Hassanand VaziraniWhole-Time Director01 May 20242 Years 6 MonthsCurrent
Suresh Hassanand VaziraniDirector01 Apr 200818 Years 7 MonthsCurrent
Mala Suresh VaziraniDirector03 Dec 201015 Years 11 MonthsCurrent
Rajendra Vadilal GandhiAdditional Director18 Jun 20251 Years 4 MonthsCurrent
Sanjay Surinder AroraDirector30 Dec 20241 Years 10 MonthsCurrent
Vibhuti Suresh VaziraniDirector01 Mar 20224 Years 8 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Auditor

Transasia Bio-Medicals Limited is audited by Walker Chandiok & Company LLP for the financial year 2025.

Auditor firmFinancial yearFirm registration number
Walker Chandiok & Company LLPFY 2025001076N/N500013

Shareholding

The shareholding of Transasia Bio-Medicals Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Transasia Bio-Medicals Limited, buy the company report.

Charges & borrowings

Open charges
₹108 Cr
Satisfied charges
₹999.7 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹42.00 Cr
Citi Bank N.A.₹30.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹20.00 Cr
The Royal Bank of Scotland N V₹16.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Jul 2018100193762The Hongkong and Shanghai Banking Corporation Limited₹20 CrOpen
21 May 201410496177Citi Bank N.A.₹30 CrOpen
07 Sep 200710072790Hdfc Bank Limited₹42 CrOpen
30 Apr 200710051810The Royal Bank of Scotland N V₹16 CrOpen
12 Jun 2019100269038The Hongkong and Shanghai Banking Corporation Limited₹109.84 CrSatisfied

To see the full charge records of Transasia Bio-Medicals Limited, buy the company report.

Total charge records: 25 View all charges

Deals & funding

Transasia Bio-Medicals Limited has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2008.

Total deals
1
Funding round
1
Disclosed funding
₹2 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Aug 2008Funding round₹2 CrInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Transasia Bio-Medicals Limited was last rated by Icra on 17 Jun 2021.

Rating agencyRated onRating
Icra17 Jun 2021

To see the full credit ratings and regulatory alerts of Transasia Bio-Medicals Limited, buy the company report.

MSME payment delays

Transasia Bio-Medicals Limited has 12 MSME Form 1 returns on record between 2018 and 2024, listing 194 overdue payments to 60 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 60)

SupplierAmount dueDue sinceReported on
Pentagon Packaging LLP
an individual supplier
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Transasia Bio-Medicals Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Transasia Bio-Medicals has 2 subsidiary companies and 1 joint venture. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

2
Subsidiary companies
1
Joint ventures
Key subsidiaries
Company NameCINShares held
Transasia Diagnostics Private LtdU24299MH2020PTC344692
Care Data Infomatics Private LimitedU72900TN2016PTC110158

To see the full group structure of Transasia Bio-Medicals Limited, buy the company report.

Employees & EPFO

Transasia Bio-Medicals Limited has a workforce of 1,323 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
1,323
Active EPFO establishments
2
Employee growth
-2.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-271,323
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Transasia Bio-Medicals Limited, buy the company report.

GST

Transasia Bio-Medicals has 18 GST registrations: 12 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
18
Active
12
Cancelled / inactive
6
GSTINStateStatusRegistered on
27AAACT2038C1ZTMaharashtraActive01 Jul 2017
27AAACT2038C3ZRMaharashtraActive19 Dec 2019
02AAACT2038C1Z5Himachal PradeshActive01 Jul 2017
08AAACT2038C1ZTRajasthanActive01 Jul 2017

To see the full GST registrations and return filing status of Transasia Bio-Medicals Limited, buy the company report.

Recent activity

Transasia Bio-Medicals Limited has 22 board changes on record since 2008: 11 appointments and 11 cessations. The latest: Shiraz Bugwadia Homi was appointed as Director on 29 Sep 2025.

AGM
Transasia Bio-Medicals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Shiraz Bugwadia Homi was appointed as Director.
Appointed
Rajendra Vadilal Gandhi was appointed as Additional Director.
Appointed
Aditi Pradeep Pai was appointed as CFO.
Filing
Transasia Bio-Medicals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Sanjay Surinder Arora was appointed as Director.
Ceased
Nishant Saxena ceased to be Additional Director.
Ceased
Aravind Viswanathan ceased to be CEO.
Appointed
Sunil Hassanand Vazirani was appointed as Whole-Time Director.
Ceased
Vibhuti Suresh Vazirani ceased to be Whole-Time Director.
Appointed
Nishant Saxena was appointed as Director.
Appointed
Ashok Kanwarlal Suthar was appointed as Company Secretary.

71 earlier events are in the company report.

Frequently asked questions

Transasia Bio-Medicals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 10 May 1985 (41+ years old) and is registered under CIN U33110MH1985PLC036198.

Transasia Bio-Medicals has 9 current directors:

The latest financial statements of Transasia Bio-Medicals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Transasia Bio-Medicals is 27AAACT2038C1ZT, registered in Maharashtra. The company has 18 GST registrations in all, of which 12 are active and 6 are cancelled or inactive. Other active GSTINs include 27AAACT2038C3ZR (Maharashtra), 02AAACT2038C1Z5 (Himachal Pradesh), 08AAACT2038C1ZT (Rajasthan).

The CIN (Corporate Identification Number) of Transasia Bio-Medicals is U33110MH1985PLC036198. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Transasia Bio-Medicals has 15,950 court cases on record: 15,815 filed by the company and 136 filed against it. 4,840 are pending. Most are in the district courts.

Transasia Bio-Medicals was incorporated on 10 May 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.

Transasia Bio-Medicals has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2008.

Shiraz Bugwadia Homi was appointed as Director on 29 Sep 2025. Rajendra Vadilal Gandhi was appointed as Additional Director on 18 Jun 2025. Aditi Pradeep Pai was appointed as CFO on 01 Apr 2025. Transasia Bio-Medicals has 22 board changes on record in total.

Transasia Bio-Medicals has 12 MSME Form 1 returns on record between 2018 and 2024, listing 194 overdue payments to 60 micro and small suppliers. The latest return was filed on 25 Apr 2024.

Transasia Bio-Medicals can be reached through the website transasia.co.in. Its registered office is in Mumbai, Maharashtra, India.